Patients who receive kidney transplants from Epstein–Barr virus D-positive/R-negative donors face a higher risk of ...

LOS ANGELES, CA / ACCESS Newswire / February 3, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is ...

In this retrospective cohort study, individuals who were Epstein-Barr virus-seronegative had higher rates of post-transplant ...

Use of immune repertoire sequencing analysis to detect differences in treatment responses for advanced esophageal squamous cell carcinoma treated with camrelizumab and platinum-based chemotherapy.

Conditions like lupus, Sjögren’s syndrome, or polymyalgia rheumatica can cause widespread fatigue alongside other symptoms ...

The following is a summary of “Increased Epstein‒Barr virus reactivation following prophylaxis for cytomegalovirus infection ...

Epstein–Barr virus-positive mucocutaneous ulcer (EBVMCU) is a rare condition characterized by skin or mucosal lesions resulting from defective immune surveillance of EBV due to immunosuppression, ...

New findings reveal how a specific immune response to the Epstein-Barr virus could trigger multiple sclerosis, highlighting the intricate link between viral infection and autoimmune disease.

Merck & Co has entered into a worldwide licensing deal with Opko Health’s ModeX Therapeutics unit for a vaccine candidate against Epstein-Barr virus (EBV) that could be worth up to $922.5 ...

Epstein-Barr virus (EBV), a member of the herpes virus family, is one of the most common human viruses. Most people are infected with EBV at some point during their lives. EBV can cause infectious ...